INOVIQ Banner Image


  • Ticker IIQ
    Exchange ASX More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
INOVIQ Logo Image
  • 11-50 Employees
  • Based in Notting Hill, Australia
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The Company has commercialised the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Their cancer diagnosticMore pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.
4.8 / 5.0 (76)

INOVIQ reports have an aggregate usefulness score of 4.8 based on 76 reviews.


Most Recent Annual Report

MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

INOVIQ Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!